Moleculin Biotech, Inc.
MBRX
$2.34
-$0.10-4.10%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 32.45% | -11.30% | -2.06% | 80.36% | -54.51% |
| Total Receivables | 16.67% | 20.00% | -16.67% | -70.00% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -35.35% | -26.65% | 276.45% | -48.14% | -74.33% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -24.25% | -10.71% | -68.98% | 300.30% | -- |
| Total Current Assets | 22.84% | -13.12% | -2.83% | 79.82% | -55.25% |
|
|
|||||
| Total Current Assets | 22.84% | -13.12% | -2.83% | 79.82% | -55.25% |
| Net Property, Plant & Equipment | -6.67% | -10.45% | -10.67% | -9.95% | -8.91% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | -- | -- | -- |
| Total Assets | 8.71% | -5.74% | 2.76% | 24.15% | -27.65% |
|
|
|||||
| Total Accounts Payable | 65.78% | -43.13% | 37.51% | 33.30% | -20.39% |
| Total Accrued Expenses | -6.55% | -15.50% | -0.05% | 26.71% | 9.63% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.79% | 3.13% | 3.23% | 3.33% | 3.45% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 20.63% | -28.19% | 14.75% | 28.68% | -4.18% |
|
|
|||||
| Total Current Liabilities | 20.63% | -28.19% | 14.75% | 28.68% | -4.18% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -13.95% | -11.64% | -10.43% | -8.94% | -8.21% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -99.89% | 101.10% | 49.49% | -- | -- |
| Total Liabilities | -84.94% | 64.38% | 37.13% | 266.82% | -64.08% |
|
|
|||||
| Common Stock & APIC | 13.52% | 21.44% | 0.27% | -12.96% | 15.56% |
| Retained Earnings | 7.02% | -32.32% | -4.78% | 7.33% | -13.84% |
| Treasury Stock & Other | 122.73% | -15.79% | 0.00% | 7.32% | -1,125.00% |
| Total Common Equity | 155.74% | -275.72% | -17,159.52% | -99.63% | 49.86% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 155.74% | -275.72% | -17,159.52% | -99.63% | 49.86% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 155.74% | -275.72% | -17,159.52% | -99.63% | 49.86% |
|
|
|||||